肝细胞癌术前血清AFP与NLR水平对判断患者预后的应用价值

摘要/Abstract

摘要： 目的探讨肝细胞癌(HCC)术前血清甲胎蛋白(AFP)与中性粒细胞与淋巴细胞比值(NLR)水平判断患者预后的价值。方法回顾性分析2014年2月～2016年2月收治的88例于我院行手术治疗的HCC患者的临床资料,依据预后情况分为预后良好组与预后不良组。比较两组性别、年龄、TNM分期、肿瘤直径、是否存在淋巴结转移、是否存在乙型肝炎病毒感染、AFP、NLR差异,通过ROC曲线分析AFP、NLR预测HCC患者预后不良的价值,最后通过多因素logistic回归分析明确HCC预后不良的危险因素。结果两组性别、年龄、是否存在乙型肝炎病毒感染对比无差异(P>0.05);预后不良组TNM分期Ⅲ或Ⅳ期、肿瘤直径≥60 mm、淋巴结转移患者显著多于预后良好组,(P<0.05);预后不良组AFP、NLR显著高于预后良好组,(P<0.05)。经ROC分析AFP、NLR预测HCC患者预后的曲线下面积分别为0.839、0.815,均有P<0.05。经多因素logistic回归分析证实,TNM分期Ⅲ或Ⅳ期、肿瘤直径≥60 mm、淋巴结转移、AFP≥444.26 ng/mL、NLR≥2.65是HCC患者预后不良的危险因素,均有P<0.05。结论 HCC的预后影响因素较多,当AFP≥444.26 ng/mL、NLR≥2.65时HCC患者预后较差,临床治疗中应当关注。

关键词: 肝细胞性肝癌, 甲胎蛋白, 中性粒细胞与淋巴细胞比值, 预

Abstract: Objective To evaluate the predictive value of preoperative serum alpha-fetoprotein (AFP) level and neutrophil-to-lymphocyte ratio (NLR) in the prognosis of patients with hepatocellular carcinoma (HCC). Methods The clinical data of 88 patients with HCC who underwent surgery in our hospital from February 2014 to February 2016 were retrospectively analyzed. According to the prognosis, they were divided into a good prognosis group and a poor prognosis group. The gender, age, the tumor, node, metastasis (TNM) stage, tumor diameter, lymph node metastasis, hepatitis B virus infection, AFP, and NLR between the 2 groups were compared. The value of AFP and NLR in predicting poor prognosis of HCC patients was analyzed by receiver operator characteristic curve. And risk factors for poor prognosis of HCC were identified by multivariate logistic regression analysis. Results There was no difference between the 2 groups in sex, age or the incidence of hepatitis B virus infection (P>0.05). In poor prognosis group, cases of TNM stage III or IV, tumor diameter ≥ 60 mm and lymph node metastasis were significantly more than those in good prognosis group (P<0.05). AFP and NLR in poor prognosis group were significantly higher than those in good prognosis group (P<0.05). The area under the curve of AFP and NLR predicting the poor prognosis of HCC patients was 0.839 and 0.815, respectively (P<0.05). Multivariate logistic regression analysis confirmed that TNM stage III or IV, tumor diameter ≥ 60 mm, lymph node metastasis, AFP ≥ 444.26 ng/mL, NLR ≥ 2.65 were risk factors for poor prognosis of HCC patients (P<0.05). Conclusion The prognosis of HCC is affected by many factors. When AFP ≥ 444.26 ng/mL or NLR ≥ 2.65, the prognosis of HCC patients tends to be poor, which should be paid attention to in clinical treatment.

Key words: Hepatocellular carcinoma, Alpha-fetoprotein, Neutrophil-to-lymphocyte ratio, Prognosis

张海业, 彭艺, 陆粵就, 何丽凤. 肝细胞癌术前血清AFP与NLR水平对判断患者预后的应用价值[J]. 肝脏, 2020, 25(8): 825-827.

ZHANG Hai-ye, PENG Yi, LU Yue-jiu, HE Li-feng. Value of preoperative serum AFP and NLR levels in predicting prognosis of HCC patients[J]. Chinese Hepatolgy, 2020, 25(8): 825-827.

[1]	张志生, 孔庆利, 梁志鹏. 不同AFP水平肝细胞癌患者手术后5年生存期比较的回顾性分析[J]. 肝脏, 2020, 25(8): 813-815.
[2]	杨瑞园, 刘立伟, 罗娟, 李轲鑫, 田秋菊, 王艳, 赵新颜, 贾继东. 药物性肝损伤致急性肝衰竭预测模型的比较研究[J]. 肝脏, 2020, 25(7): 671-675.
[3]	马向明, 侯婧悦, 付庆江, 曹立瀛. 线粒体丙酮酸载体在肝细胞癌中的表达及临床意义[J]. 肝脏, 2020, 25(6): 573-577.
[4]	刘铁峰, 许澍妮, 吴姗姗. 血清p62及LC3-Ⅱ联合检测对HBV-ACLF患者近期预后的价值[J]. 肝脏, 2020, 25(6): 582-584.
[5]	唐巧萍, 段志强, 乔悾. 钠离子通道调节蛋白1与肝癌患者3年预后的相关性研究[J]. 肝脏, 2020, 25(6): 610-611.
[6]	李银珍, 杜日昌, 丁宇, 徐彤, 廖罗飞. 肝内胆管细胞癌患者EGFR和Her-2表达水平评估预后的应用价值[J]. 肝脏, 2020, 25(6): 614-616.
[7]	王敏. 肝癌患者自发性破裂出血的影响因素及预后因素分析[J]. 肝脏, 2020, 25(5): 510-513.
[8]	杨永红, 孙阳, 李小兰, 李小松, 孟燕. 妊娠期肝内胆汁淤积症孕产妇血清胆汁酸水平与肝功能和妊娠结局的相关性[J]. 肝脏, 2020, 25(5): 544-547.
[9]	刘栋, 苏康乐, 张翠杰, 翟亚玲, 李芳华. 肾小管HBAg阳性表达与HBV相关肾功能损伤预后的关系[J]. 肝脏, 2020, 25(4): 372-374.
[10]	高朋彬, 郑欢伟, 赵晓彦, 王德华, 秦浩, 孟明辉, 张建集, 闫双缓. 内科综合治疗HBV-ACLF患者的临床特点及转归[J]. 肝脏, 2020, 25(4): 375-378.
[11]	赵梦, 陈明, 王丽, 胡孙裔. 自身免疫性肝炎患儿临床特点与预后[J]. 肝脏, 2020, 25(4): 379-381.
[12]	李飞, 郭振添, 莫海兴, 丁爱娇, 张拔山. 血清spHBV及PIVKA-Ⅱ联合检测对HBV所致肝癌的预测价值[J]. 肝脏, 2020, 25(4): 412-415.
[13]	程静, 徐路, 彭素琼. 肝血流超声参数联合外周血vWF-Ag对肝硬化患者食管静脉曲张出血的预测价值[J]. 肝脏, 2020, 25(3): 260-263.
[14]	王雨, 许达峰, 周开伦, 武金才, 丁驿超, 古海强, 谢明微, 林明花. TLR4和肠道菌群在原发性肝癌进展中动态变化及与预后的关系[J]. 肝脏, 2020, 25(3): 273-276.
[15]	冯文杏, 周小舟, 韩志毅, 孙新锋, 马文峰, 张卫. GALAD模型在诊断HBV相关肝细胞癌中的价值探讨[J]. 肝脏, 2020, 25(3): 291-294.

肝细胞癌术前血清AFP与NLR水平对判断患者预后的应用价值

Value of preoperative serum AFP and NLR levels in predicting prognosis of HCC patients

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价